Alternatively activated macrophages (M2 macrophages) in the skin of patient with localized scleroderma
Authors:
- 24 July 2009
- journal article
- Published by Wiley in Experimental Dermatology
- Vol. 18 (8) , 727-729
Abstract
Abstract: Localized scleroderma is a connective tissue disorder that is limited to the skin and subcutaneous tissue. Macrophages have been reported to be particularly activated in patients with skin disease including systemic sclerosis and are potentially important sources for fibrosis‐inducing cytokines, such as transforming growth factor β. To clarify the features of immunohistochemical characterization of the immune cell infiltrates in localized scleroderma focusing on macrophages, skin biopsy specimens were analysed by immunohistochemistry. The number of cells stained with monoclonal antibodies, CD68, CD163 and CD204, was calculated. An evident macrophage infiltrate and increased number of alternatively activated macrophages (M2 macrophages) in their fibrotic areas were observed along with their severity of inflammation. This study revealed that alternatively activated macrophages (M2 macrophages) may be a potential source of fibrosis‐inducing cytokines in localized scleroderma, and may play a crucial role in the pathogenesis of localized scleroderma.Keywords
This publication has 27 references indexed in Scilit:
- Alternatively activated macrophages in protozoan infectionsCurrent Opinion in Immunology, 2007
- A macrophage marker, siglec‐1, is increased on circulating monocytes in patients with systemic sclerosis and induced by type i interferons and toll‐like receptor agonistsArthritis & Rheumatism, 2007
- Anti-agalactosyl immunoglobulin G antibodies in localized sclerodermaInternational Journal of Dermatology, 2005
- Alternative activation of macrophagesNature Reviews Immunology, 2003
- Clinical significance of serum levels of soluble interleukin-2 receptor in patients with localized sclerodermaBritish Journal of Dermatology, 1996
- Clinical significance of serum levels of soluble interleukin-2 receptor in patients with localized sclerodermaBritish Journal of Dermatology, 1996
- Demonstration of interleukin-2, interleukin-4 and interleukin-6 in sera from patients with localized sclerodermaArchives of Dermatological Research, 1995
- Demonstration of interleukin 8 in serum samples of patients with localized sclerodermaArchives of Dermatology, 1994
- Increased levels of circulating intercellular adhesion molecule-1 in patients with localized sclerodermaJournal of the American Academy of Dermatology, 1994
- Antihistone antibodies in patients with localized sclerodermaArthritis & Rheumatism, 1993